Cancer Epidemiology Biomarkers & Prevention, Vol 7, Issue 9 783-789, Copyright © 1998 by American Association for Cancer Research

ARTICLES

Menstrual factors in relation to breast cancer risk

L Titus-Ernstoff, MP Longnecker, PA Newcomb, B Dain, ER Greenberg, R Mittendorf, M Stampfer and W Willett
Department of Community and Family Medicine, Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire 03756, USA.

We evaluated menstrual factors in relation to breast cancer risk in a large, population-based, case-control study. Case women were ascertained through state-wide registries covering Wisconsin, Western Massachusetts, Maine, and New Hampshire; control women were randomly selected from driver's license and Medicare lists in each state. Information regarding menstrual characteristics was obtained through a telephone interview. The study population comprised 6888 breast cancer cases and 9529 control women. Because exogenous hormones influence menstrual cycle patterns, we repeated our analyses in a subgroup of women who had never used oral contraceptives or hormone replacement therapy. Our results indicate decreased breast cancer risk with menarcheal age of 15 years or more, relative to menarche at age 13; the relation was stronger among premenopausal [odds ratio (OR), 0.72; 95% confidence interval (CI), 0.57-0.91] as opposed to postmenopausal women (OR, 0.90; 95% CI, 0.80-1.03). Risk was slightly reduced among premenopausal women whose menstrual cycles did not become regular until at least 5 years after onset of menses, relative to those whose cycles became regular within 1 year (OR, 0.80; 95% CI, 0.63-1.02). There was no clear relation between breast cancer risk and irregular menstrual cycles, episodes of amenorrhea, or menstrual cycle length. Early menopause, whether natural or surgical, was associated with decreased breast cancer risk; surgical menopause before age 40 conferred the strongest protective effect (OR, 0.57; 95% CI, 0.47-0.71). We found no evidence of increased risk with late natural menopause (OR, 0.92; 95% CI, 0.80-1.06). Results in the subgroup of women who never used exogenous hormones were similar to those for the entire group.

This article has been cited by other articles:

				C. N. Holick, P. A. Newcomb, A. Trentham-Dietz, L. Titus-Ernstoff, A. J. Bersch, M. J. Stampfer, J. A. Baron, K. M. Egan, and W. C. Willett Physical Activity and Survival after Diagnosis of Invasive Breast Cancer Cancer Epidemiol. Biomarkers Prev., February 1, 2008; 17(2): 379 - 386. [Abstract] [Full Text] [PDF]

				J. L. Kramer, I. A. Velazquez, B. E. Chen, P. S. Rosenberg, J. P. Struewing, and M. H. Greene Prophylactic Oophorectomy Reduces Breast Cancer Penetrance During Prospective, Long-Term Follow-Up of BRCA1 Mutation Carriers J. Clin. Oncol., December 1, 2005; 23(34): 8629 - 8635. [Abstract] [Full Text] [PDF]

				Y.-C. Shen, C.-J. Chang, C. Hsu, C.-C. Cheng, C.-F. Chiu, and A.-L. Cheng Significant Difference in the Trends of Female Breast Cancer Incidence Between Taiwanese and Caucasian Americans: Implications from Age-Period-Cohort Analysis Cancer Epidemiol. Biomarkers Prev., August 1, 2005; 14(8): 1986 - 1990. [Abstract] [Full Text] [PDF]

				K. L. Terry, W. C. Willett, J. W. Rich-Edwards, D. J. Hunter, and K. B. Michels Menstrual Cycle Characteristics and Incidence of Premenopausal Breast Cancer Cancer Epidemiol. Biomarkers Prev., June 1, 2005; 14(6): 1509 - 1513. [Abstract] [Full Text] [PDF]

				M. Chavez-MacGregor, S. G. Elias, N. C. Onland-Moret, Y. T. van der Schouw, C. H. Van Gils, E. Monninkhof, D. E. Grobbee, and P. H.M. Peeters Postmenopausal Breast Cancer Risk and Cumulative Number of Menstrual Cycles Cancer Epidemiol. Biomarkers Prev., April 1, 2005; 14(4): 799 - 804. [Abstract] [Full Text] [PDF]

				M. D. Althuis, J. H. Fergenbaum, M. Garcia-Closas, L. A. Brinton, M. P. Madigan, and M. E. Sherman Etiology of Hormone Receptor-Defined Breast Cancer: A Systematic Review of the Literature Cancer Epidemiol. Biomarkers Prev., October 1, 2004; 13(10): 1558 - 1568. [Abstract] [Full Text] [PDF]

				J. Chubak, S. S. Tworoger, Y. Yasui, C. M. Ulrich, F. Z. Stanczyk, and A. McTiernan Associations between Reproductive and Menstrual Factors and Postmenopausal Sex Hormone Concentrations Cancer Epidemiol. Biomarkers Prev., August 1, 2004; 13(8): 1296 - 1301. [Abstract] [Full Text] [PDF]

				L. B. Travis, D. A. Hill, G. M. Dores, M. Gospodarowicz, F. E. van Leeuwen, E. Holowaty, B. Glimelius, M. Andersson, T. Wiklund, C. F. Lynch, et al. Breast Cancer Following Radiotherapy and Chemotherapy Among Young Women With Hodgkin Disease JAMA, July 23, 2003; 290(4): 465 - 475. [Abstract] [Full Text] [PDF]

				D. S. Freedman, L. K. Khan, M. K. Serdula, W. H. Dietz, S. R. Srinivasan, and G. S. Berenson Relation of Age at Menarche to Race, Time Period, and Anthropometric Dimensions: The Bogalusa Heart Study Pediatrics, October 1, 2002; 110(4): e43 - 43. [Abstract] [Full Text] [PDF]

				A. Must, S.M. Phillips, E.N. Naumova, M. Blum, S. Harris, B. Dawson-Hughes, and W. M. Rand Recall of Early Menstrual History and Menarcheal Body Size: After 30 Years, How Well Do Women Remember? Am. J. Epidemiol., April 1, 2002; 155(7): 672 - 679. [Abstract] [Full Text] [PDF]

				F. Clavel-Chapelon Evolution of age at menarche and at onset of regular cycling in a large cohort of French women Hum. Reprod., January 1, 2002; 17(1): 228 - 232. [Abstract] [Full Text] [PDF]

				L. Hilakivi-Clarke, E. Cho, S. deAssis, S. Olivo, E. Ealley, K. B. Bouker, J. N. Welch, G. Khan, R. Clarke, and A. Cabanes Maternal and Prepubertal Diet, Mammary Development and Breast Cancer Risk J. Nutr., January 1, 2001; 131(1): 154S - 157. [Full Text]

				L. Hilakivi-Clarke Estrogens, BRCA1, and Breast Cancer Cancer Res., September 1, 2000; 60(18): 4993 - 5001. [Abstract] [Full Text]